Agreed, reads better to me a lay person and provides greater confidence in the drug’s value proposition and hence future adoption.
Given that we are already at AUD $756 Mn (about USD$500 Mn) is the potential upside including acquisition multiple max of 10X of current MC?
Ann: Additional COBRA trial data results, page-4
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.50 |
Change
0.040(0.90%) |
Mkt cap ! $1.399B | |||
| Open | High | Low | Value | Volume |
| $4.48 | $4.66 | $4.44 | $6.943M | 1.538M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 372 | $4.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.50 | 27571 | 1 |
View Market Depth
| Last trade - 16.10pm 28/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$4.53 |
Change
0.040 ( 1.67 %) |
||||
| Open | High | Low | Volume | ||
| $4.51 | $4.66 | $4.45 | 71724 | ||
| Last updated 15.59pm 28/05/2024 ? | |||||
| CU6 (ASX) Chart |